DEFINING PROSTATE SPECIFIC ANTIGEN PROGRESSION AFTER RADICAL PROSTATECTOMY: WHAT IS THE MOST APPROPRIATE CUT POINT?
- 1 April 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (6) , 1146-1151
- https://doi.org/10.1097/00005392-200104000-00020
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniquesUrology, 1999
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate CancerJournal of Clinical Oncology, 1999
- Black Race is an Adverse Prognostic Factor for Prostate Cancer Recurrence Following Radical Prostatectomy in an Equal Access Health Care SettingJournal of Urology, 1996
- 1016 Biochemical outcome following external beain radiation therapy for T1–2 prostate carcinoma: the importance of achieving an undetectable nadir PSAInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate CancerJournal of Urology, 1994
- The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancerCancer, 1993
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988
- Analysis of survival by tumor response.Journal of Clinical Oncology, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958